Skip to main content
Fig. 5 | Molecular Neurodegeneration

Fig. 5

From: Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease

Fig. 5

Validation of shared and divergent CSF protein levels across AD and race. A Schematic of experimental workflow for SRM analysis of cerebrospinal fluid proteome B Heatmap of peptides that were significantly differentially expressed between control and AD Caucasians or African Americans. Stars are indicative of the level of significant difference (*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001) seen for each peptide between AD and control within each race. Meanwhile the colors are indicative of the log2 fold change (FC) of each peptide from control and AD for each race where blue is indicative of the degree of decrease and shade of red is indicative of the degree of increase. C Log2 abundance of peptides that mapped to modules of interest distributed by race and diagnosis. Pairwise significance was calculated using one-way ANOVA with Tukey adjustment

Back to article page